These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3000589

  • 21. Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture.
    Proper JA, Bjornson CL, Moses HL.
    J Cell Physiol; 1982 Feb; 110(2):169-74. PubMed ID: 6279682
    [Abstract] [Full Text] [Related]

  • 22. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
    Hudgins WR, Orth DN, Stromberg K.
    Cancer Res; 1988 Mar 15; 48(6):1428-34. PubMed ID: 3257897
    [Abstract] [Full Text] [Related]

  • 23. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice.
    Twardzik DR, Kimball ES, Sherwin SA, Ranchalis JE, Todaro GJ.
    Cancer Res; 1985 May 15; 45(5):1934-9. PubMed ID: 3872712
    [Abstract] [Full Text] [Related]

  • 24. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
    Kuratomi Y, Ono M, Yasutake C, Mawatari M, Kuwano M.
    J Cell Physiol; 1987 Jan 15; 130(1):51-7. PubMed ID: 3468117
    [Abstract] [Full Text] [Related]

  • 25. Epithelial tissue-derived growth factor-like polypeptides.
    Halper J, Moses HL.
    Cancer Res; 1983 May 15; 43(5):1972-9. PubMed ID: 6572559
    [Abstract] [Full Text] [Related]

  • 26. Elevated growth factor levels in transformed mouse embryo cells treated with N,N-dimethylformamide.
    Levine AE, Hamilton DA, McRae LJ, Brattain MG.
    Cancer Res; 1985 Jan 15; 45(1):108-11. PubMed ID: 2981156
    [Abstract] [Full Text] [Related]

  • 27. Effect of phorbol esters on the activity of purified transforming growth factors.
    Kraft AS.
    Cancer Res; 1986 Apr 15; 46(4 Pt 1):1764-7. PubMed ID: 3004705
    [Abstract] [Full Text] [Related]

  • 28. Characterization of autostimulatory and transforming growth factors from human melanoma cells.
    Richmond A, Lawson DH, Nixon DW, Chawla RK.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6390-4. PubMed ID: 3864531
    [Abstract] [Full Text] [Related]

  • 29. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
    Liu C, Tsao MS, Grisham JW.
    Cancer Res; 1988 Feb 15; 48(4):850-5. PubMed ID: 3276400
    [Abstract] [Full Text] [Related]

  • 30. Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors.
    Siegfried JM.
    Cancer Res; 1987 Jun 01; 47(11):2903-10. PubMed ID: 3032416
    [Abstract] [Full Text] [Related]

  • 31. Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings.
    Sanfilippo JS, Rao CV, Guarnaschelli JJ, Woost PG, Byrd VM, Jones E, Schultz GS.
    Surg Gynecol Obstet; 1993 Nov 01; 177(5):488-96. PubMed ID: 8211601
    [Abstract] [Full Text] [Related]

  • 32. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.
    Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB.
    Proc Natl Acad Sci U S A; 1981 Sep 01; 78(9):5339-43. PubMed ID: 6975480
    [Abstract] [Full Text] [Related]

  • 33. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F.
    Pircher R, Lawrence DA, Jullien P.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5538-43. PubMed ID: 6093998
    [Abstract] [Full Text] [Related]

  • 34. Transforming growth factors.
    Roberts AB, Sporn MB.
    Cancer Surv; 1985 Dec 01; 4(4):683-705. PubMed ID: 2890434
    [Abstract] [Full Text] [Related]

  • 35. Autocrine secretion of peptide growth factors by tumor cells.
    Todaro GJ.
    Natl Cancer Inst Monogr; 1982 Dec 01; 60():139-47. PubMed ID: 6289103
    [Abstract] [Full Text] [Related]

  • 36. A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients.
    Eckert K, Granetzny A, Fischer J, Nexø E, Grosse R.
    Cancer Res; 1990 Feb 01; 50(3):642-7. PubMed ID: 2297705
    [Abstract] [Full Text] [Related]

  • 37. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
    Stromberg K, Hudgins WR, Fryling CM, Hazarika P, Dedman JR, Pardue RL, Hargreaves WR, Orth DN.
    J Cell Biochem; 1986 Feb 01; 32(4):247-59. PubMed ID: 3492500
    [Abstract] [Full Text] [Related]

  • 38. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB.
    Cancer Res; 1994 Sep 01; 54(17):4703-9. PubMed ID: 8062268
    [Abstract] [Full Text] [Related]

  • 39. Identification of a 15,000-molecular-weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary.
    Riss TL, Sirbasku DA.
    J Cell Physiol; 1989 Feb 01; 138(2):393-404. PubMed ID: 2918041
    [Abstract] [Full Text] [Related]

  • 40. Production of transforming growth factors by human colon cancer lines.
    Coffey RJ, Shipley GD, Moses HL.
    Cancer Res; 1986 Mar 01; 46(3):1164-9. PubMed ID: 3002610
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.